Latest News and Press Releases
Want to stay updated on the latest news?
-
ST. LOUIS, March 15, 2019 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it...
-
First patients successfully treated with robust integration of technologiesIntegrated technologies now commercially available ST. LOUIS and CARLSBAD, Calif., March 15, 2019 (GLOBE NEWSWIRE) --...
-
Record high annual recurring revenue of $27.8 million; 3% annual growthPositive annual net income for the first time in Company history despite significantly increased R&D investmentsInnovation...
-
ST. LOUIS, March 04, 2019 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it...
-
ST. LOUIS, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that...
-
ST. LOUIS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias announced today a partnership...
-
ST. LOUIS, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that...
-
Continued progress on strategic innovation initiatives; expect to showcase in 1H 20194% recurring revenue growth; reaffirming 2018 record recurring revenue expectationsConference call today at 10:00...
-
ST. LOUIS, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it...
-
ST. LOUIS, Mo., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced...